Key features and details
- Rabbit polyclonal to Cdk6 (phospho Y13)
- Suitable for: IHC-P, WB, ICC/IF
- Reacts with: Mouse, Human
- Isotype: IgG
Product nameAnti-Cdk6 (phospho Y13) antibody
See all Cdk6 primary antibodies
DescriptionRabbit polyclonal to Cdk6 (phospho Y13)
Tested applicationsSuitable for: IHC-P, WB, ICC/IFmore details
Species reactivityReacts with: Mouse, Human
Synthetic peptide within Human Cdk6 (phospho Y13). The exact sequence is proprietary.
Database link: Q00534
- 293 cell lysate; Human breast carcinoma tissue and HeLa cells
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.30
Preservative: 0.02% Sodium azide
Constituents: 49% PBS, 50% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab194871 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/50 - 1/100.|
|WB||1/500 - 1/2000. Predicted molecular weight: 37 kDa.|
|ICC/IF||1/100 - 1/200.|
FunctionProbably involved in the control of the cell cycle. Interacts with D-type G1 cyclins.
Sequence similaritiesBelongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.
Contains 1 protein kinase domain.
- Information by UniProt
- CDK 6 antibody
- CDK6 antibody
- CDK6_HUMAN antibody
All lanes : Anti-Cdk6 (phospho Y13) antibody (ab194871) at 1/500 dilution
Lane 1 : Untreated 293 cell lysate
Lane 2 : 293 cell lysate treated with HU
Predicted band size: 37 kDa
Immunofluorescent staining of methanol-fixed HeLa cells labeling Cdk6 (phospho Y13) using ab194871 at 1/100 dilution.
Immunohistochemical staining of Human breast carcinoma tissue labeling Cdk6 (phospho Y13) using ab194871 at 1/50 dilution.
ab194871 has been referenced in 1 publication.
- Shi X et al. Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer. Oncol Rep 40:1592-1600 (2018). PubMed: 29956794